{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:21:37Z","timestamp":1792178497730,"version":"4.4.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI134842"],"award-info":[{"award-number":["R01AI134842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.it.2023.11.005","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T16:14:51Z","timestamp":1703002491000},"page":"48-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Chimeric antigen receptor Treg therapy in transplantation"],"prefix":"10.1016","volume":"45","author":[{"given":"Siawosh K.","family":"Eskandari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Daccache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil R.","family":"Azzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2023.11.005_bb0005","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.93.6.2264","article-title":"Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires","volume":"93","author":"Goodnow","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.11.005_bb0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2807","article-title":"The origins of vertebrate adaptive immunity","volume":"10","author":"Litman","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0015","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","article-title":"Regulatory immune cells in transplantation","volume":"12","author":"Wood","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0030","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2023.11.005_bb0040","first-page":"432","article-title":"Renal homotransplantation in identical twins","volume":"6","author":"Murray","year":"1956","journal-title":"Surg. Forum"},{"key":"10.1016\/j.it.2023.11.005_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s002680010124","article-title":"History of clinical transplantation","volume":"24","author":"Starzl","year":"2000","journal-title":"World J. Surg."},{"key":"10.1016\/j.it.2023.11.005_bb0050","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation","volume":"385","author":"Hariharan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0055","series-title":"Transplantation of the Liver","first-page":"1354","article-title":"Long-term toxicity of immunosuppressive therapy","author":"Ruiz","year":"2015"},{"key":"10.1016\/j.it.2023.11.005_bb0060","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1681\/ASN.2009101043","article-title":"Long-term cancer risk of immunosuppressive regimens after kidney transplantation","volume":"21","author":"Gallagher","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.it.2023.11.005_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2009.06.001","article-title":"First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127\u2212 T regulatory cells","volume":"133","author":"Trzonkowski","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0070","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0075","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0080","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0085","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (the ONE study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.it.2023.11.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061864","article-title":"Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients","volume":"12","author":"Brook","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.it.2023.11.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91599","article-title":"Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation","volume":"2","author":"Sula Karreci","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.11.005_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.11.005_bb0110","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41581-023-00733-w","article-title":"Regulatory T cells in autoimmune kidney diseases and transplantation","volume":"19","author":"Mikami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.it.2023.11.005_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2017.01.001","article-title":"Generation of human islet-specific regulatory T cells by TCR gene transfer","volume":"79","author":"Hull","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2023.11.005_bb0120","doi-asserted-by":"crossref","first-page":"19078","DOI":"10.1073\/pnas.0907396106","article-title":"Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis","volume":"106","author":"Wright","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0125","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-019-10097-0","article-title":"Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response","volume":"10","author":"Baeuerle","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2023.11.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5191","article-title":"Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41591-021-01621-1","article-title":"HLA-independent T cell receptors for targeting tumors with low antigen density","volume":"28","author":"Mansilla-Soto","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41586-023-06706-0","article-title":"Targeting of intracellular oncoproteins with peptide-centric CARs","volume":"623","author":"Yarmarkovich","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0145","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3389\/fimmu.2019.02250","article-title":"Engineered T cell therapy for cancer in the clinic","volume":"10","author":"Zhao","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0150","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2014.41","article-title":"Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells","volume":"22","author":"Blat","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.it.2023.11.005_bb0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0160","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.abq6990","article-title":"The future of engineered immune cell therapies","volume":"378","author":"Irvine","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.it.2023.11.005_bb0165","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.3390\/cells12162115","article-title":"Development of beta-amyloid-specific CAR-Tregs for the treatment of Alzheimer's disease","volume":"12","author":"Saetzler","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.it.2023.11.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102961","article-title":"Flagellin-specific human CAR Tregs for immune regulation in IBD","volume":"134","author":"Boardman","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2023.11.005_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.581433","article-title":"Antigen specificity enhances disease control by Tregs in vitiligo","volume":"11","author":"Mukhatayev","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104222","article-title":"Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression","volume":"358","author":"De Paula Pohl","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0185","doi-asserted-by":"crossref","first-page":"18.13","DOI":"10.4049\/jimmunol.206.Supp.18.13","article-title":"Generation of islet antigen-specific engineered Tregs for use in T1D therapy via homology-directed gene editing of conventional CD4+ T cells","volume":"206","author":"Yang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1207108","article-title":"Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes","volume":"14","author":"Obarorakpor","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0195","article-title":"Tregs with an MHC class II peptide\u2013specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2023.11.005_bb0200","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2023.11.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136185","article-title":"CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD","volume":"5","author":"Imura","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.11.005_bb0210","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160674","article-title":"Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses","volume":"7","author":"Bolivar-Wagers","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.11.005_bb0215","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.11.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001612","article-title":"FOXP3 promoter demethylation reveals the committed Treg population in humans","volume":"3","author":"Janson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.it.2023.11.005_bb0230","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0235","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.it.2023.11.005_bb0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for Scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0250","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","article-title":"Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients","volume":"177","author":"Battaglia","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899975","article-title":"mTORC1 inhibition protects human regulatory T cells from granzyme-B-induced apoptosis","volume":"13","author":"Eskandari","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2019.00038","article-title":"Automated clinical grade expansion of regulatory T cells in a fully closed system","volume":"10","author":"Mar\u00edn Morales","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0265","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.11.005_bb0270","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.3522","article-title":"Affinity for self antigen selects Treg cells with distinct functional properties","volume":"17","author":"Wyss","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-018-0083-6","article-title":"Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation","volume":"19","author":"Klein","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0280","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2012-05-431023","article-title":"A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells","volume":"121","author":"McMurchy","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0285","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/eji.200737594","article-title":"DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells","volume":"37","author":"Baron","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0290","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2018.07.014","article-title":"Epigenetic mechanisms regulating T-cell responses","volume":"142","author":"Schmidl","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0295","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1073\/pnas.0900621106","article-title":"Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR\u03b3t","volume":"106","author":"Ayyoub","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0300","article-title":"Engineered Treg cells: the heir to the throne of immunotherapy","author":"Stucchi","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2023.11.005_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.611638","article-title":"Super-Treg: toward a new era of adoptive Treg therapy enabled by genetic modifications","volume":"11","author":"Amini","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.it.2023.11.005_bb0315","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcyt.2020.10.002","article-title":"HLA-A*02:01-directed chimeric antigen receptor\/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease","volume":"23","author":"Martin","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.it.2023.11.005_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2023.11.005_bb0325","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2023.11.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126194","article-title":"Chimeric antigen receptor costimulation domains modulate human regulatory T cell function","volume":"4","author":"Boroughs","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.11.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0340","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167215","article-title":"Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection","volume":"8","author":"Rosado-S\u00e1nchez","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2023.11.005_bb0345","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1002\/eji.202048934","article-title":"Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive","volume":"51","author":"Mohseni","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0350","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41571-021-00476-2","article-title":"Immunogenicity of CAR T cells in cancer therapy","volume":"18","author":"Wagner","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.it.2023.11.005_bb0355","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-019-0737-3","article-title":"Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma","volume":"26","author":"Brudno","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0360","series-title":"Transplantation Immunology: Methods and Protocols","first-page":"157","article-title":"HLA typing and its influence on organ transplantation","author":"Sheldon","year":"2006"},{"key":"10.1016\/j.it.2023.11.005_bb0365","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonz\u00e1lez-Galarza","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.it.2023.11.005_bb0370","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of allograft rejection by use of regulatory T cells with an MHC-specific chimeric antigen receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0375","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of human regulatory T cells in preventing human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0380","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0385","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.it.2023.11.005_bb0390","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/tan.13926","article-title":"Rapid, highly accurate and cost-effective open-source simultaneous complete HLA typing and phasing of class I and II alleles using nanopore sequencing","volume":"96","author":"Stockton","year":"2020","journal-title":"HLA"},{"key":"10.1016\/j.it.2023.11.005_bb0395","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.humimm.2020.06.004","article-title":"Utilizing nanopore sequencing technology for the rapid and comprehensive characterization of eleven HLA loci; addressing the need for deceased donor expedited HLA typing","volume":"81","author":"Mosbruger","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0400","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.humimm.2021.01.010","article-title":"New challenges, new opportunities: next generation sequencing and its place in the advancement of HLA typing","volume":"82","author":"Bravo-Egana","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0405","article-title":"Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in cynomolgus macaque","volume":"3","author":"Ellis","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/TP.0b013e31817352b9","article-title":"H-Y antibody development associates with acute rejection in female patients with male kidney transplants","volume":"86","author":"Tan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.it.2023.11.005_bb0415","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2003-11-3763","article-title":"Transplantation tolerance induced by intranasal administration of HY peptides","volume":"103","author":"Chai","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0420","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.immunol.15.1.39","article-title":"The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning","volume":"15","author":"Simpson","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0425","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1073\/pnas.0800149105","article-title":"Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression","volume":"105","author":"Verginis","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1139358","article-title":"Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution","volume":"14","author":"Halawi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0435","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3389\/fimmu.2020.01608","article-title":"The future of regulatory T cell therapy: promises and challenges of implementing CAR technology","volume":"11","author":"Mohseni","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0445","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0450","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41591-022-01960-7","article-title":"Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy","volume":"28","author":"Good","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.746889","article-title":"Utilization of Treg cells in solid organ transplantation","volume":"13","author":"Juneja","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0460","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.1091667","article-title":"Gene therapy insertional mutagenesis insights","volume":"303","author":"Dav\u00e9","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.it.2023.11.005_bb0465","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/ajt.15787","article-title":"Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients","volume":"20","author":"Sicard","year":"2020","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0470","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 Annual Data Report: kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0475","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/ajt.14029","article-title":"Treg-centric view of immunosuppressive drugs in transplantation: a balancing act","volume":"17","author":"Camirand","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0480","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/ajt.12934","article-title":"Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer","volume":"14","author":"Singh","year":"2014","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.it.2023.11.005_bb0485","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2010.06.001","article-title":"IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25\u2212 cell activation","volume":"132","author":"Wang","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.it.2023.11.005_bb0495","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20050783","article-title":"Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo","volume":"203","author":"Tadokoro","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0500","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.11.005_bb0505","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0510","doi-asserted-by":"crossref","first-page":"41525","DOI":"10.1074\/jbc.M110.189944","article-title":"Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells","volume":"285","author":"Yan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2023.11.005_bb0515","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.immuni.2014.05.019","article-title":"MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells","volume":"41","author":"Okoye","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.it.2023.11.005_bb0520","doi-asserted-by":"crossref","first-page":"16246","DOI":"10.1073\/pnas.1007422107","article-title":"Enhancement of antigen-specific Treg vaccination in vivo","volume":"107","author":"Daniel","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6422","article-title":"Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function","volume":"12","author":"Honaker","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0530","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0535","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41586-018-0830-7","article-title":"De novo design of potent and selective mimics of IL-2 and IL-15","volume":"565","author":"Silva","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0540","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw4744","article-title":"Regulatory T cells engineered with TCR signaling-responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter","volume":"12","author":"Eskandari","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103341","article-title":"Inducing chimeric antigen receptor (CAR) regulatory T cells in vivo: a novel concept for a potential feasible cure of demyelinating diseases","volume":"57","author":"Sedaghat","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.it.2023.11.005_bb0555","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-bioeng-071813-104938","article-title":"Viral vectors for gene therapy: translational and clinical outlook","volume":"17","author":"Kotterman","year":"2015","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.it.2023.11.005_bb0560","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1073\/pnas.83.10.3194","article-title":"Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells","volume":"83","author":"Yu","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.it.2023.11.005_bb0565","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.it.2023.11.005_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112931","article-title":"A method for expansion and retroviral transduction of mouse regulatory T cells","volume":"488","author":"Wu","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.it.2023.11.005_bb0575","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omtm.2020.11.008","article-title":"Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors","volume":"20","author":"Vimond","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.it.2023.11.005_bb0580","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/nprot.2013.111","article-title":"Generation of T cell receptor-retrogenic mice: improved retroviral-mediated stem cell gene transfer","volume":"8","author":"Bettini","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.it.2023.11.005_bb0585","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0590","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymthe.2019.10.001","article-title":"Simultaneous deletion of endogenous TCR\u03b1\u03b2 for TCR gene therapy creates an improved and safe cellular therapeutic","volume":"28","author":"Morton","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.it.2023.11.005_bb0595","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/ni.3004","article-title":"Continuous requirement for the TCR in regulatory T cell function","volume":"15","author":"Levine","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0600","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2018.02.006","article-title":"Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology","volume":"90","author":"Koristka","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2023.11.005_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102931","article-title":"CAR-T design: elements and their synergistic function","volume":"58","author":"Jayaraman","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.it.2023.11.005_bb0610","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0615","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/374168a0","article-title":"A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks","volume":"374","author":"Greenberg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0620","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.it.2023.11.005_bb0625","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24903","article-title":"Affimer proteins are versatile and renewable affinity reagents","volume":"6","author":"Tiede","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.it.2023.11.005_bb0630","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/molecules24234229","article-title":"Aptamers: a review of their chemical properties and modifications for therapeutic application","volume":"24","author":"Adachi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.it.2023.11.005_bb0635","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010611-134654","article-title":"Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy","volume":"55","author":"Pl\u00fcckthun","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.it.2023.11.005_bb0640","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature23912","article-title":"Massively parallel de novo protein design for targeted therapeutics","volume":"550","author":"Chevalier","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.it.2023.11.005_bb0645","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.cji.0000161397.96582.59","article-title":"The role of extracellular spacer regions in the optimal design of chimeric immune receptors","volume":"28","author":"Guest","year":"2005","journal-title":"J. Immunother."},{"key":"10.1016\/j.it.2023.11.005_bb0650","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/2326-6066.CIR-14-0127","article-title":"The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity","volume":"3","author":"Hudecek","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.it.2023.11.005_bb0655","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","article-title":"A safe and potent anti-CD19 CAR T cell therapy","volume":"25","author":"Ying","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0660","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/cells9051182","article-title":"Hinge and transmembrane domains of chimeric antigen receptor regulate receptor expression and signaling threshold","volume":"9","author":"Fujiwara","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.it.2023.11.005_bb0665","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: property, design and functionality","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.it.2023.11.005_bb0670","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639818","article-title":"The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28","volume":"12","author":"Muller","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.it.2023.11.005_bb0675","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0680","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2023.11.005_bb0685","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0690","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2023.11.005_bb0695","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41551-022-00896-0","article-title":"Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains","volume":"6","author":"Gordon","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.it.2023.11.005_bb0700","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2013.192","article-title":"Arming cytokine-induced killer cells with chimeric antigen receptors: cd28 outperforms combined CD28\u2013OX40 'super-stimulation'","volume":"21","author":"Hombach","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.it.2023.11.005_bb0705","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.it.2023.11.005_bb0710","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.it.2023.11.005_bb0715","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm.4478","article-title":"A novel chimeric antigen receptor containing a JAK\u2013STAT signaling domain mediates superior antitumor effects","volume":"24","author":"Kagoya","year":"2018","journal-title":"Nat. Med."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490623002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:13:26Z","timestamp":1761462806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490623002594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1471490623002594"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2023.11.005","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric antigen receptor Treg therapy in transplantation","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}